2025-2034 Drug-Coated Balloons Market Roadmap: Insights for Competitive Advantage

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Drug-Coated Balloons Market Size By 2025?
The market scale of drug-coated balloons has seen a swift expansion in the past few years. The market size is predicted to rise from $1.08 billion in 2024 to $1.24 billion in 2025, experiencing a compound annual growth rate (CAGR) of 15.4%. The growth in the past period can be linked to the rising burden of cardiovascular diseases, the growing demand for less invasive procedures, the increasing rate of peripheral artery disease (PAD), reduction in restenosis rates, and advancements in interventional cardiology.

How Big Is the Drug-Coated Balloons Market Size Expected to Grow by 2029?
Projected to experience swift expansion over the next few years, the drug-coated balloons market size is estimated to reach $2.22 billion in 2029 with a compound annual growth rate (CAGR) of 15.6%. Attrbuting factors for the expansion during the projected period include a rise in the aged population, broadening of indications and application, shifting focus towards outpatient and ambulatory care, combined drug delivery breakthroughs, and worldwide health strategies. The prediction period will witness significant trends such as regulatory sanctioning for novel formulations, emphasis on reducing side effects, the rise of bioresorbable coatings, market growth in developing economies, and patient-focused strategies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

Which Key Market Drivers Powering Drug-Coated Balloons Market Expansion and Growth?
The expected increase in instances of coronary artery disease may act as a catalyst for the growth of the drug-coated balloons market. The narrowing or blockage of the coronary arteries, which supply blood to the heart muscle, is referred to as coronary artery disease (CAD). This can result in heart attacks. To treat this medical condition, a novel medical device, the drug-coated balloon is used. During the procedure, the drug is released into the artery to inhibit restenosis, the recurring constriction of the artery post-angioplasty. For example, a study published in the Journal of the American College of Cardiology in August 2022, noted an anticipated increase in all four cardiovascular risk factors among the general U.S. population from 2025 to 2060. Diabetes was seen as the risk factor with the most significant forecasted increase of 39.3%, followed by dyslipidemia (27.6%), hypertension (25.1%), and obesity (18.3%). Furthermore, the research indicated the potential for major increases in heart failure (33.4%) and ischemic heart disease (30.7%) rates, with heart attacks (16.9%) and strokes (33.8%) following suit. Due to a predicted increase in the prevalence of coronary artery disease, the market for drug-coated balloons is expected to expand.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Drug-Coated Balloons Market?
The introduction of new products is a dominant trend in the drug-coated balloon market, as leading firms are channeling their resources to come up with advanced and innovative solutions to solidify their standing in the market. For instance, Becton, Dickinson, and Company (BD), a renowned medical technology firm based in the US, initiated the pioneering PREVISION first-in-human trial for a peripheral sirolimus drug-coated balloon (DCB) in August 2022. The intent of this trial is to evaluate the safety and efficacy of the sirolimus DCB in treating individuals suffering from peripheral artery disease, a condition that severely affects mobility and overall life quality.

What Are the Emerging Segments in the Drug-Coated Balloons Market?
The drug-coated balloons market covered in this report is segmented -

1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease, Drug-Coated Balloons For Other Indications
2) By Drug Type: Paclitaxel, Sirolimus
3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers

Subsegments:
1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons
2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons, Everolimus-Coated Balloons
3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions, Drug-Coated Balloons For Renal Artery Lesions, Drug-Coated Balloons For Other Vascular Applications

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10829&type=smp

Who Are the Global Leaders in the Drug-Coated Balloons Market?
Major companies operating in the drug-coated balloons market include Acotec Scientific AG, B. Braun Melsungen AG, Biosensors International Group Ltd, Medtronic Inc., Boston Scientific Corporation, Opto Circuits, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed

Which are the Top Profitable Regional Markets for the Drug-Coated Balloons Industry?
North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10829

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.